Literature DB >> 17597475

Crimean-Congo hemorrhagic fever: five patients with hemophagocytic syndrome.

Nuriye Tasdelen Fisgin1, Tunc Fisgin, Esra Tanyel, Levent Doganci, Necla Tulek, Nil Guler, Feride Duru.   

Abstract

Three pediatric and two adult Turkish patients with Crimean Congo Hemorrhagic Fever (CCHF) induced hemophagocytic syndrome (HPS) were admitted to Ondokuz Mayis University Hospital, which is in the Middle Black Sea Region of Turkey. All of them had remarkable hemophagocytosis in the bone marrow with severe bleeding symptoms along with the other known clinical and laboratory findings of CCHF. We would like to present these patients and to discuss the pathophysiology and the effect of acquired HPS on the severity of the disease.

Entities:  

Mesh:

Year:  2008        PMID: 17597475     DOI: 10.1002/ajh.20969

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  7 in total

1.  The role of ribavirin in the therapy of Crimean-Congo hemorrhagic fever: early use is promising.

Authors:  N Tasdelen Fisgin; O Ergonul; L Doganci; N Tulek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-03-20       Impact factor: 3.267

2.  Serum resistin levels may be new prognostic factor of crimean-congo hemorrhagic fever.

Authors:  Ayse Erturk; Erkan Cure; Emine Parlak; Medine Cumhur Cure; Suleyman Yuce; Bayram Kizilkaya
Journal:  Int J Clin Exp Med       Date:  2014-10-15

3.  Can serum ferritin level predict disease severity in patients with crimean-congo hemorrhagic Fever?

Authors:  Maliheh Metanat; Batool Sharifi-Mood; Mehdi Tabatabaei; Mohammad Sarraf-Shirazi
Journal:  Eurasian J Med       Date:  2013-06

4.  Sepsis due to Streptococcus pneumoniae associated with secondary hemophagocytic lymphohistiocytosis in a splenectomized patient for spherocytosis: A case report.

Authors:  Victoria Birlutiu; Rares Mircea Birlutiu
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 5.  Hemophagocytic lymphohistiocytosis: review of etiologies and management.

Authors:  Melissa R George
Journal:  J Blood Med       Date:  2014-06-12

6.  Macrophage Activation Marker Soluble CD163 Associated with Fatal and Severe Ebola Virus Disease in Humans1.

Authors:  Anita K McElroy; Punya Shrivastava-Ranjan; Jessica R Harmon; Roosecelis B Martines; Luciana Silva-Flannery; Timothy D Flietstra; Colleen S Kraft; Aneesh K Mehta; G Marshall Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Sherif R Zaki; Christina F Spiropoulou
Journal:  Emerg Infect Dis       Date:  2019-02       Impact factor: 6.883

Review 7.  The Impact of Tick-Borne Diseases on the Bone.

Authors:  Imran Farooq; Tara J Moriarty
Journal:  Microorganisms       Date:  2021-03-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.